{
    "resourceType": "CodeSystem",
    "id": "v2-0477",
    "meta": {
        "profile": [
            "http://hl7.org/fhir/StructureDefinition/shareablecodesystem"
        ]
    },
    "language": "en",
    "text": {
        "status": "additional",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Controlled Substance Schedule</p>\r\n<table class=\"grid\"><tr><td><b>Code</b></td><td><b>Description</b></td><td><b>Comment</b></td><td><b>Version</b></td></tr><tr><td>I<a name=\"I\"> </a></td><td>Schedule I</td><td>Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.</td><td>added v2.5</td></tr><tr><td>II<a name=\"II\"> </a></td><td>Schedule II</td><td>Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.</td><td>added v2.5</td></tr><tr><td>III<a name=\"III\"> </a></td><td>Schedule III</td><td>Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.</td><td>added v2.5</td></tr><tr><td>IV<a name=\"IV\"> </a></td><td>Schedule IV</td><td>Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.</td><td>added v2.5</td></tr><tr><td>V<a name=\"V\"> </a></td><td>Schedule V</td><td>Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.</td><td>added v2.5</td></tr><tr><td>VI<a name=\"VI\"> </a></td><td>Schedule VI</td><td>State defined</td><td>added v2.5</td></tr></table>\r\n</div>"
    },
    "extension": [
        {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
            "valueCode": "external"
        },
        {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
            "valueInteger": 0
        }
    ],
    "url": "http://terminology.hl7.org/CodeSystem/v2-0477",
    "identifier": [
        {
            "system": "urn:ietf:rfc:3986",
            "value": "urn:oid:2.16.840.1.113883.18.304"
        }
    ],
    "version": "2.9",
    "name": "v2.0477",
    "title": "v2 Controlled Substance Schedule",
    "status": "active",
    "experimental": false,
    "publisher": "HL7, Inc",
    "contact": [
        {
            "telecom": [
                {
                    "system": "url",
                    "value": "http://hl7.org"
                }
            ]
        }
    ],
    "description": "FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)",
    "content": "complete",
    "concept": [
        {
            "extension": [
                {
                    "url": "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
                    "valueString": "Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."
                }
            ],
            "code": "I",
            "display": "Schedule I"
        },
        {
            "extension": [
                {
                    "url": "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
                    "valueString": "Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."
                }
            ],
            "code": "II",
            "display": "Schedule II"
        },
        {
            "extension": [
                {
                    "url": "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
                    "valueString": "Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."
                }
            ],
            "code": "III",
            "display": "Schedule III"
        },
        {
            "extension": [
                {
                    "url": "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
                    "valueString": "Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."
                }
            ],
            "code": "IV",
            "display": "Schedule IV"
        },
        {
            "extension": [
                {
                    "url": "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
                    "valueString": "Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."
                }
            ],
            "code": "V",
            "display": "Schedule V"
        },
        {
            "extension": [
                {
                    "url": "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
                    "valueString": "State defined"
                }
            ],
            "code": "VI",
            "display": "Schedule VI"
        }
    ]
}